Executive summary Acting now on dementia prevention, intervention, and care will vastly
improve living and dying for individuals with dementia and their families, and in doing so …

Background Aggression, agitation or psychosis occur in the majority of people with dementia
at some point in the illness. There have been a number of trials of atypical antipsychotics to …

The number of older people, including those living with dementia, is rising, as younger age
mortality declines. However, the age-specific incidence of dementia has fallen in many …

Background Data from 12-week placebo-controlled trials have led to mounting concerns
about increased mortality in patients with Alzheimer's disease (AD) who are prescribed …

The coronavirus disease 2019 (COVID-19) pandemic is having a profound effect on all
aspects of society, including mental health and physical health. We explore the psychological, …

The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about
the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in …

An estimated 24 million people worldwide have dementia, the majority of whom are thought
to have Alzheimer's disease. Thus, Alzheimer's disease represents a major public health …

Cerebrovascular disease is the second most common cause of acquired cognitive impairment
and dementia and contributes to cognitive decline in the neurodegenerative dementias. …

‘Brain training’, or the goal of improved cognitive function through the regular use of computerized
tests, is a multimillion-pound industry 1 , yet in our view scientific evidence to support …

Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …